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Background: Gingival margin-derived stem/progenitor cells (G-MSCs) show remarkable periodontal regenerative 
potential in vivo. During regeneration, G-MSCs may interact with their inflammatory environment via toll-like-
receptors (TLRs). The present study aimed to depict the G-MSCs TLRs expression profile. 
Material and Methods: Cells were isolated from free gingival margins, STRO-1-immunomagnetically sorted and 
seeded to obtain single colony forming units (CFUs). G-MSCs were characterized for CD14, CD34, CD45, CD73, 
CD90, CD105, CD146 and STRO-1 expression, and for multilineage differentiation potential. Following G-MSCs’ 
incubation in basic or inflammatory medium (IL-1β, IFN-γ, IFN-α, TNF-α) a TLR expression profile was gene-
rated. 
Results: G-MSCs showed all stem/progenitor cells’ characteristics. In basic medium G-MSCs expressed TLRs 1, 
2, 3, 4, 5, 6, 7, and 10. The inflammatory medium significantly up-regulated TLRs 1, 2, 4, 5, 7 and 10 and dimi-
nished TLR 6 (p≤0.05, Wilcoxon-Signed-Ranks-Test). 
Conclusions: The current study describes for the first time the distinctive TLRs expression profile of G-MSCs 
under uninflamed and inflamed conditions.
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Introduction
The human gingiva covers the tooth-bearing alveolar 
bone with its inserting teeth. One of its distinguished 
features is its significant regenerative and wound hea-
ling capacity with little if any evidence of scarring (1). 
The numerous functions of gingival connective tissue 
fibroblasts, their broad spectrum in responsiveness to 
growth/differentiation factors as well as in the capacity 
to produce an array of specific extracellular matrix pro-
teins during healing demonstrates their heterogeneous 
nature (2-6) and implies the presence of a population 
of stem/progenitor cells, giving rise to these heteroge-
neous cells. Earlier studies described the isolation of 
stem/progenitor cells from oral soft tissues (7-12). Cu-
rrent investigations reported promising characteristics 
of gingival stem/progenitor cells, including its immu-
nomodulatory properties (13) as well as their compati-
bility with alginate hydrogel microbeads scaffolds (14). 
In a recent study, free gingival margin-derived stem/
progenitor cells (G-MSCs) demonstrated a remarkable 
regenerative capacity in vivo (15).
Toll-like receptors (TLRs), major molecules linking the 
innate and adaptive immunity, are germ line-encoded 
pattern-recognition receptors (PRRs) detecting speci-
fic pathogen-associated molecular patterns (PAMPs), 
thereby promoting immune cells’ activation (16,17). 
They function as sensors for invading pathogens and 
are involved in autoimmune, chronic inflammatory 
and infectious diseases’ pathogenesis (18). To date, 10 
functional human TLRs have been characterized (19). 
Depending on their cellular localization and their PAMP 
ligands, TLRs are divided into extracellular and intra-
cellular ones. The first group is expressed on the cell 
surface and they mostly identify microbial membrane 
constituents including lipids and lipoproteins (TLR1, 
TLR2, and TLR6), lipopolysaccharide (LPS) (TLR4), 
and flagellin (TLR5). The second group is expressed in-
tracellularly, where they identify double-stranded RNA 
(TLR3), single-stranded viral RNA (TLR7 and TLR8) 
and unmethylated CpG DNA of viruses and bacteria 
(TLR9) (20).
Multipotent stromal cells (MSCs) of different origin 
have been shown to express functional TLRs in specific 
patterns, making them selectively sensitive to micro-
bial compounds. When triggered TLRs can modulate 
MSCs’ proliferative, immunosuppressive, migratory 
and differentiation potentials (19,21-23). Differential 
expressions of TLRs 1, 2, 3, 4, 5, 6, were described on 
human and mural adipose and bone marrow derived 
MSCs, on human umbilical cord blood MSCs (UCB-
MSCs), on human Wharton Jelly MSCs (WJ-MSCs), 
and on human MSCs from the dental pulp and the dental 
follicle (22,24,25). Results showed that the specific pat-
tern of TLRs expression varies according to the MSCs’ 
tissue of origin, which could have an implication on the 
MSCs’ therapeutic potential during transplantation in 
inflammatory environments in-vivo (26).
G-MSCs are currently experimentally employed in the-
rapeutic modalities for inflammatory conditions inclu-
ding the treatment of periodontitis (15) and colitis (13). 
To date no TLRs’ expression profile exists for the G-
MSCs. The aim of the present study is to characterize 




- Isolation and culture of G-MSCs
G-MSCs isolation was done as previously described 
(27). Briefly, after obtaining the patients’ informed 
consent (Ethical Committee IRB- Approval number 
D 444/10), free gingival collars from five individuals 
(n=5) were surgically excised at the department of pe-
riodontology of the Christian-Albrechts-University-
Kiel, Germany. The free gingival tissue collars were 
detached, de-epithelised, cut into small pieces, rinsed 
several times with Minimum Essential Medium Eagle 
Alpha Modification (α-MEM; Sigma-Aldrich GmbH, 
Hamburg, Germany) supplemented with antibiotics (100 
U/ml penicillin, 100 µg/ml streptomycin) and 1% am-
photericine (all from Biochrom AG, Berlin, Germany) 
and placed into dry 75 ml culture flasks (Sarstedt AG, 
Nümbrecht, Germany) for 30 minutes to adhere to their 
bottoms. Subsequently, the basic medium consisting of 
α-MEM, supplemented with 15% fetal calf serum (FCS; 
HyClone, Logan, UT, USA), 400 mmol/ml L-glutamine 
(Biochrom), 100 U/ml penicillin, 100 µg/ml streptomy-
cin and 1% amphotericine was carefully added. The 
flasks were incubated in 5% carbon dioxide at 37°C and 
cells left to grow out. The culture flasks were periodica-
lly checked by phase contrast inverted microscopy and 
the basic medium changed three times per week. After 
reaching 80-85% confluence, cells were detached with 
0.10% trypsin-EDTA (Biochrom) and counted. Their 
viability was tested using Trypan Blue (Sigma-Aldrich) 
to be finally seeded at a density of 30 cells/cm² in 75 
ml culture flask in basic medium and the flasks were 
incubated in 5% carbon dioxide at 37°C. After the first 
passage cells reached 80-85% confluence, they were 
subjected to immunomagnetic cell sorting using anti-
STRO-1 (BioLegend, San Diego, CA, USA) and anti-
IgM MicroBeads (Miltenyi Biotec, Bergisch Gladbach, 
Germany) antibodies according to the manufacturers’ 
instructions (MACS; Miltenyi Biotec). The positively 
sorted cell fractions (G-MSCs) were seeded out to form 
colony-forming units (CFUs).
- Colony-forming units (CFUs) 
To assess colony-forming efficiency, G-MSCs were cul-
tured in basic medium at a density of 1.63 cells/cm2. 
Aggregates of 50 or more cells were scored as colonies. 
On day 12 a representative sample of the cultures were 
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fixed with 4% formalin, stained with 0.1% crystal violet. 
From the remainder of the CFUs forming G-MSCs sin-
gle colonies were then detached by cell scrapers (28,29) 
and seeded in new 75 ml flasks in basic medium.
- Flow cytometric analysis
After reaching confluence, a sample of the G-MSCs 
were characterized by flow cytometry for the predefi-
ned MSCs’ surface marker constellation (30); namely 
CD14, CD34, CD45, CD73, CD90 and CD105 (all from 
Becton Dickinson). Binding of the primary antibodies 
and the corresponding isotype controls was performed 
according to standard protocols using FcR Blocking 
Reagent (Miltenyi Biotec) and evaluated with FACS-
Calibur E6370 and FACSComp 5.1.1 software (Becton 
Dickinson). 
- Multilineage differentiation potential
To test for osteogenic differentiation potential, third pas-
sage 2×104 G-MSCs were cultured on 6-well culture 
plates in osteogenic inductive medium (PromoCell, Hei-
delberg, Germany). As controls, G-MSCs were cultured 
in basic medium. At day 14, cell cultures were stained 
with Alizarin Red (Sigma-Aldrich) (30), to label calcified 
deposits. To test the adipogenic differentiation potential, 
third passage 3×105 G-MSCs were cultured on 6-well cul-
ture plates in adipogenic inductive medium (PromoCell). 
As a control G-MSCs were cultured in basic medium. 
The presence of lipid drops was evaluated by staining 
with Oil-Red-O (Sigma-Aldrich) (30). To test the chon-
drogenic differentiation potential, micro-masses of third 
passage 3×104 G-MSCs were incubated with chondroge-
nic inductive medium (PromoCell) in 6-well culture pla-
tes (Sarstedt AG, Germany). As a control, G-MSCs were 
cultured in basic medium. Chondrogenic differentiation 
was evaluated at day 35 by staining of glycosaminogly-
cans with Alcian Blue (Sigma-Aldrich) (30,31). All media 
were renewed three times per week.
- Inflammatory medium
To test the effect of the inflammatory environment on 
the G-MSCs TLR expression profile, a combination of 
25 ng/ml IL-1β, 103 U/ml IFN- γ, 50 ng/ml TNF-α, and 
3×103 U/ml IFN-α (inflammatory medium, all from Pe-
proTech, Hamburg, Germany) (32) was used. G-MSCs 
were incubated for 18 hours in the inflammatory me-
dium (G-MSCs-i) as well as basic medium (G-MSCs).
- Flow cytometric determination of TLR expression 
G-MSCs and G-MSCs-i were characterized by flow 
cytometry for the presence of the different TLRs 1-10 
at protein level. For intracellular TLRs staining, cells 
were fixed, permeabilized with Fix & Perm cell per-
meabilization kit (Imtec, Antwerpen, Belgium) before 
incubation. The following antibodies were used: anti-
TLR1, anti-TLR3 and anti-TLR9 (all from eBioscience), 
anti-TLR2, anti-TLR4 and anti-TLR8 (all from Enzo 
Life Sciences, Lörrach Germany), anti-TLR5 (R&D 
Systems, Hessen, Germany), anti-TLR6 (BioLegend), 
anti-TLR7 (Perbio Science, Bonn, Germany) and anti-
TLR10 (Acris Antibodies, Herford, Germany). Binding 
of the primary antibodies and the corresponding isotype 
controls was performed according to standard protocols 
using FcR Blocking Reagent (Miltenyi Biotec) and eva-
luated with FACSCalibur E6370 and FACSComp 5.1.1 
software (Becton Dickinson). 
- m-RNA Extraction and cDNA Synthesis
m-RNA extraction was performed for G-MSCs and G-
MSCs-i using the RNeasy kit (Qiagen, Hilden, Germany) 
according to manufacturer’s instructions. The obtained 
RNA was purified using RNase-free-DNase (Promega, 
Mannheim, Germany), and quantified photometrically. 
Complementary cDNA was synthesized from 1-13µl 
of RNA (1 µg/µl) by reverse transcription (RT) using 
QuantiTect reverse transcription kit (Qiagen) according 
to the manufacturer’s instructions (Mastercycler gra-
dient; Eppendorf) in a volume of 20 µl reaction mixture 
containing 4 pmol of each primer, 10µl of the LightCy-
cler Probes Master mixture (Roche Diagnostics) and 5 
µl specimen cDNA. Real time polymerase chain reac-
tion (rt-PCR; LightCycler 96 Real-Time PCR System, 
Roche Molecular Biochemicals, Indianapolis, Indiana, 
USA) was performed according to the manufacturer’s 
instructions. Relative quantities of each transcript were 
normalized according to the expression of PGK1. Pri-
mers for TLRs 1 to 10 and the reference gene PGK1 
were supplied by Roche and tested on G-MSCs and G-
MSCs-i (Table 1).
- Statistical analysis
The Shapiro-Wilk-Test was used to test normal distri-
bution of the data. Differences in TLRs’ expression on 
m-RNA and Protein levels in G-MSCs and G-MSCs-i 
were evaluated using the nonparametric Wilcoxon Sig-
ned Rank test using SPSS software (SPSS version 11.5, 
SPSS, Chicago, IL). The level of significance was set at 
p=0.05.
Assay ID Gene Symbol Accession ID 
111000 TLR1 H. sapiens ENST00000308979 
145617 TLR2 H. sapiens ENST00000260010 
111008 TLR3 H. sapiens ENST00000296795 
135752 TLR4 H. sapiens ENST00000355622 
103674 TLR5 H. sapiens ENST00000366881 
111018 TLR6 H. sapiens ENST00000381950 
111012 TLR7 H. sapiens ENST00000380659 
103816 TLR8 H. sapiens ENST00000218032 
143252 TLR9 H. sapiens ENST00000360658 
141065 TLR10 H. sapiens NM_001017388 
102083 PGK1 H. sapiens ENST00000373316 
Table 1. Primer names and ID used for real-time PCR (as supplied 
by Roche)
Abbreviations: TLR: Toll-like receptor; PGK1: Phosphglycerate 
kinase 1.
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Results
- Phase contrast inverted microscopy, colony forming 
units and Flow cytometric analysis
Following the initial adherence phase, cells grew out of 
the gingival tissue masses, forming adherent fibroblast-
like clusters (Fig. 1A). Twelve days after seeding, G-
MSCs showed CFUs (Fig. 1B). G-MSCs were negative 
for CD14, CD34 and CD45 while positive for CD73, 
CD90 and CD105 (Fig. 1C).
- Multilineage differentiation potential
Osteogenic differentiation of G-MSCs was demonstrat-
ed by the formation of calcified deposits labelled with 
Alizarin Red in contrast to their controls (Fig. 1D,E). 
Adipogenic differentiation of G-MSCs resulted in the 
formation of lipid droplets that were positively stained 
with Oil-Red-O in contrast to their controls (Fig. 1F,G). 
Chondrogenic differentiation of G-MSCs resulted in the 
formation of glycosaminoglycans positively stained with 
Alcian Blue in contrast to their controls (Fig. 1H,I). 
- Flow cytometric TLR expression 
G-MSCs incubated in basic medium expressed (Me-
dian Fluorescence Intensity, Q25/Q75) TLR1 (8.12, 
3.91/11.33), TLR2 (26.33, -2.21/41.72), TLR3 (5.79, 
0.23/15.90), TLR4 (13.89, 12.92/22.63), TLR5 (7.16, 
5.43/15.67), TLR6 (3.25, 0.53/11.73), TLR7 (7.83, 
5.48/9.74), and TLR10 (1.16, -6.70/14.96) (Fig. 2A,B). 
The inflammatory medium significantly up-regulated 
the expression of TLR1 (25.82, 18.37/37.92, p=0.043), 
TLR2 (280.51, 213/354.90, p=0.043), TLR4 (105.19, 
91.46/120.83, p=0.043), TLR5 (242.84, 216.80/287.38, 
p=0.043), TLR7 (24.41, 17.08/38.39, p=0.043) and 
TLR10 (55.83, 51.32/96.44, p=0.043), while TLR6 was 
no longer expressed on G-MSCs-i (-38.58, -51.64/-35.82, 
p=0.043, Wilcoxon Signed Ranks Test) (Fig. 2C,D). No 
difference was noted for the expression of TLR3 in 
both media. On the protein level, both G-MSCs and G-
MSCs-i did not express TLRs 8 and 9.
- TLRs’ m-RNA expression
On the m-RNA level G-MSCs incubated in basic me-
dium expressed (Median gene copies/PGK2copies, 
Q25/Q75) TLR1 (0.0037, 0.0005/0.0171), TLR2 (0.0035, 
0.0002/0.0175), TLR3 (0.0091, 0.0065/0.0678), TLR4 
(0.0118, 0.0000/0.0760), TLR5 (0.0001, 0.0000/0.0001), 
TLR6 (0.0018, 0.0004/0.0085), TLR7 (0.0000, 
0.0000/0.0001),TLR8 (0.0000, 0.0000/0.0003) and 
TLR10 (0.0000, 0.0000/0.0002) (Fig. 3A). G-MSCs-i 
showed a significantly higher expression of  TLR1 (0.0172, 
0.0094/0.0611, p=0.043), TLR3 (0.0629, 0.0449/0.1805, 
p=0.043) and TLR7 (0.0015, 0.0011/0.0022, p=0.043, 
Wilcoxon Signed Ranks Test) in addition to downregu-
lated TLR6 and TLR10 (Fig. 3B).
Discussion
In the field of tissue engineering, therapeutic appro-
aches may employ direct G-MSCs’ transplantation into 
inflamed environment (13,15), resulting ultimately in a 
direct interaction between the G-MSCs and the PAMPs 
through their TLRs. The aim of the present study was 
to characterize for the first time the distinctive TLRs’ 
expression profile of G-MSCs in inflamed as well as in 
uninflamed conditions as a first stage of exploring this 
possible interaction.
Similar to previous studies (15,27) the putative stem 
cell marker, STRO-1, implemented to isolate and puri-
fy bone marrow stromal stem cells (BMSSCs) (33) and 
alveolar bone proper-derived stem/progenitor cells (34) 
using immunomagnetic cell selection has been exploi-
ted to isolate the G-MSCs. The characterized G-MSCs 
showed all classical features defined for MSCs (30,35), 
being positive for CD73, CD90 and CD105, while nega-
tive for CD14, CD45 and CD45, as well as demonstra-
ting a remarkable CFUs ability, plastic adherence and a 
multilineage differentiation potential, into osteogenic, 
adipogenic and chondrogenic directions. 
The development of an inflammation follows most tis-
sue injuries, being an integral part of the early healing 
process. Transplanted MSCs are exposed to such sti-
muli in many clinical and therapeutic conditions. Even 
under clinically healthy conditions or after a successful 
anti-inflammatory periodontal therapy, the periodontal 
tissues show histologically pre-inflammatory conditions 
(36). Previous studies demonstrated MSCs’ sensitivity 
to inflammation (24,32,37,38). In the current study, G-
MSCs were cultured in a medium supplemented with 
IL-1β, IFN- γ, TNF-α, and IFN-α, the cytokines mostly 
present at inflammatory sites (24) as well as in basic 
medium.
On protein level, the G-MSCs in uninflamed condition 
showed a distinctive expression profile of TLRs 1, 2, 3, 
4, 5, 6, 7 and 10 in different quantities without TLR8 
and TLR9 expression. According to their median ex-
pression values, TLR2 was highest expressed followed 
by TLRs 4, 1, 7, 5, 3, 6 and finally 10. The inflammatory 
medium significantly up-regulated the expression of 
TLRs 1, 2, 4, 5, 7, and 10 and diminished TLR6 expres-
sion in G-MSC-i. It further partially altered the quanti-
tative order of expression with TLR2 remaining highest 
expressed followed by TLRs 5, 4, 10, 1, 7 and finally 3. 
The m-RNA level of most G-MSCs’ TLRs in inflamed 
and uninflamed conditions correlated with the protein 
expression, with a statistically significant upregulation 
reached for TLRs 1, 3 and 7 and a downregulation in 
TLR6. 
Contrasting TLRs expression profiles have been repor-
ted on human MSCs originating from different tissues. 
TLRs 1, 2, 3, 4, 5, 6 and 9 were expressed in umbilical 
cord blood MSCs (39,40). Bone marrow derived MSCs 
showed a broader expression pattern with added TLRs 
8 and 10 expression (41-43). Wharton jelly’s MSCs de-
monstrated a comparable pattern with marginal or defi-
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Fig. 1. Microscopic appearance, colony-formation, surface marker expression and differentiation potential: 
(A) Phase contrast microscopic appearance of the adherent tissue mass with outgrowing cells (2nd week). 
(B) Colony-forming units of G-MSCs (crystal violet). (C) Flow cytometric analysis of the surface marker 
expression profile of G-MSCs. Multilineage differentiation potential of G-MSCs. Alizarin Red staining of 
the osteogenically stimulated G-MSCs (D) and their controls (E) Oil-Red-O staining of the adipogenically 
stimulated G-MSCs (F) and their controls (G). Alcian Blue staining of the chondrogenically stimulated G-
MSCs (H) and their controls (I).
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cient expression of TLR4 (41,44). Studies on dental tis-
sue derived MSCs recorded the expression of TLRs 2, 
3 and 4 in dental follicle MSCs (45,46) and dental pulp 
MSCs (45,47). TLRs 1, 2, 3, 4, 5, 6, 8, 9 and 10 were 
expressed in periodontal ligament MSCs (43). Similar 
to our results inflammation tended to upregulate the ex-
pression of TLR2 (42,48), TLR4 (42,49) and TLR7 (48) 
as well as to downregulate the expression of TLR6 (42) 
in BM-MSCs. 
The currently outlined TLR expression profile, espe-
cially under inflammation, may influence the G-MSCs’ 
therapeutic potential in-vivo. An upregulation of the 
LPS sensing TLRs 2 (50,51) and 4 (51,52) could increase 
the G-MSCs’ ability to recognize gram-negative perio-
dontal pathogens, including Aggregatibacter actinomy-
cetemcomitans, Porphyromonas gingivalis, Prevotella 
intermedia and Tannerella forsythia. The inflammatory 
upregulation of TLR5 expression could also favor the re-
cognition of bacterial flagellin of periodontal pathogens 
(52,53) as Treponema denticola (54,55), Campylobacter 
rectus (55,56) and Eubacterium species (55,57). TLR1 
and TLR2 upregulation could favor lipoproteins’ recog-
nition (55), while an upregulated TLR7 and TLR9 will 
heighten the ability to recognize viral pathogens (58,59).
Fig. 2. Median Flouresence Intensity (MFI) of expressed TLRs in G-MSC and G-MSC-i: (A) Median Fluorescence Intensity (MFI) of ex-
pressed TLRs 1-10 of G-MSCs (green curve) and of their isotype controls (red curve) after incubation in basic medium. (B) Protein expression 
of TLRs 1-10 (n=5;box- and whisker plots with medians and quartiles). (C) Median Fluorescence Intensity (MFI) of expressed TLRs 1-10 of 
G-MSCs (green curve) and of their isotype controls (red curve) after incubation in inflammatory medium (G-MSCs-i). (D) Protein expression 
of TLRs 1-10 after incubation in inflammatory medium (n=5; box- and whisker plots with medians and quartiles). The green colored boxes 
show increased MFI after stimulation by the inflammatory medium (Wilcoxon Signed Rank test, statistical significance marked with asterisk, 
*:p<0.05). 
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The current study describes for the first time the dis-
tinctive TLRs’ expression profile of G-MSCs in infla-
med and uninflamed conditions, which could impact its 
therapeutic potential in inflammatory environments in-
vivo (26). In light of the present results, inflammation 
tends to upregulate most TLRs’ expression, promoting 
the ability of G-MSCs to recognize important periodon-
tal PAMP in-vivo.
Fig. 3. Differences in mRNA expression of TLRs 1-10 in G-MSCs and G-MSC-i: 
(A) m-RNA expression of TLRs 1-10 in uninflamed condition. (B) m-RNA expres-
sion of TLRs 1 to 10 in inflamed condition (n=5; box- and whisker plots with medi-
ans and quartiles). The green colored boxes show increased mRNA expression after 
stimulation by the inflammatory medium (Wilcoxon Signed Rank test, statistical 
significance marked with asterisk, *:p<0.05).
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